{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,3]],"date-time":"2026-03-03T23:21:52Z","timestamp":1772580112556,"version":"3.50.1"},"reference-count":10,"publisher":"Japanese Society of Internal Medicine","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2005]]},"DOI":"10.2169\/internalmedicine.44.307","type":"journal-article","created":{"date-parts":[[2005,5,17]],"date-time":"2005-05-17T06:04:45Z","timestamp":1116309885000},"page":"307-310","source":"Crossref","is-referenced-by-count":13,"title":["Hypercalcemia in a Patient with Primary Hyperparathyroidism and Acromegaly: Distinct Roles of Growth Hormone and Parathyroid Hormone in the Development of Hypercalcemia"],"prefix":"10.2169","volume":"44","author":[{"given":"Misako","family":"UEDA","sequence":"first","affiliation":[{"name":"Department of Metabolism, Endocrinology and Molecular Medicine, Osaka City University Graduate School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masaaki","family":"INABA","sequence":"additional","affiliation":[{"name":"Department of Metabolism, Endocrinology and Molecular Medicine, Osaka City University Graduate School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hideki","family":"TAHARA","sequence":"additional","affiliation":[{"name":"Department of Metabolism, Endocrinology and Molecular Medicine, Osaka City University Graduate School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasuo","family":"IMANISHI","sequence":"additional","affiliation":[{"name":"Department of Metabolism, Endocrinology and Molecular Medicine, Osaka City University Graduate School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hitoshi","family":"GOTO","sequence":"additional","affiliation":[{"name":"Department of Metabolism, Endocrinology and Molecular Medicine, Osaka City University Graduate School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshiki","family":"NISHIZAWA","sequence":"additional","affiliation":[{"name":"Department of Metabolism, Endocrinology and Molecular Medicine, Osaka City University Graduate School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"962","reference":[{"key":"1","unstructured":"1) David Heath. Regulating of Calcium Metabolism: Hypercalcemia. In: Clinical Endocrinology, ch.39, pp 515-526. Ed. Ashley Grossman. London: Blackwell Scientific Publications, 1992."},{"key":"2","doi-asserted-by":"crossref","unstructured":"2) Lund B, Eskildsen PC, Norman AW, Sorensen OH. Calcium and vitamin D metabolism in acromegaly. Acta Endocrinol (Copenh) <b>96<\/b>: 444-450, 1981.","DOI":"10.1530\/acta.0.0960444"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3) Bianda T, Hussain MA, Glatz Y, Bouillon R, Froesch ER, Schmid C. Effects of short-term insulin-like growth factor-I or growth hormone treatment on bone turnover, renal phosphate reabsorption and 1, 25 dihydroxyvitamin D3 production in healthy man. J Intern Med <b>241<\/b>: 143-150, 1997.","DOI":"10.1046\/j.1365-2796.1997.94101000.x"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4) Inaba M, Nagasue K, Okuno S, et al. Impaired secretion of parathyroid hormone, but not refractoriness of osteoblast, is a major mechanism of low bone turnover in hemodialyzed patients with diabetes mellitus. Am J Kidney Dis <b>39<\/b>: 1261-1269, 2002.","DOI":"10.1053\/ajkd.2002.33400"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5) Gray RW, Garthwaite TL. Activation of renal 1, 25-dihydroxyvitamin D3 synthesis by phosphate deprivation: evidence for a role for growth hormone. Endocrinology <b>116<\/b>: 189-193, 1985.","DOI":"10.1210\/endo-116-1-189"},{"key":"6","doi-asserted-by":"publisher","DOI":"10.1007\/s002239900303"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7) Parkinson C, Kassem M, Heickendorff L, Flyvbjerg A, Trainer PJ. Pegvisomant-induced serum insulin-like growth factor-I normalization in patients with acromegaly returns elevated markers of bone turnover to normal. J Clin Endocrinol Metab <b>88<\/b>: 5650-5655, 2003.","DOI":"10.1210\/jc.2003-030772"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8) Broadus AE, Horst RL, Lang R, Littledike ET, Rasmussen H. The importance of circulating 1, 25-dihydroxyvitamin D in the pathogenesis of hypercalciuria and renal-stone formation in primary hyperparathyroidism. N Engl J Med <b>302<\/b>: 421-426, 1980.","DOI":"10.1056\/NEJM198002213020801"},{"key":"9","doi-asserted-by":"publisher","DOI":"10.1016\/0003-9861(73)90010-6"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10) Henry HL, Midgett RJ, Norman AW. Regulation of 25-hydroxyvitamin D3-1-hydroxylase in vivo. J Biol Chem <b>249<\/b>: 7584-7592, 1974.","DOI":"10.1016\/S0021-9258(19)81278-4"}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/44\/4\/44_4_307\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,11]],"date-time":"2021-07-11T01:00:17Z","timestamp":1625965217000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/44\/4\/44_4_307\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005]]},"references-count":10,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2005]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.44.307","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005]]}}}